Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Azopharma Product Development Group Announces Opening of a New Facility in South Florida

By Pharmaceutical Processing | February 25, 2008

Azopharma Product Development Group, Inc. has announced the opening of a new facility in South Florida. The new 22,000 sq. ft. facility is home to Azopharma’s formulation development services, small-scale manufacturing, development services and specialized analytical services. The expanded facility allows for small scale manufacturing from 30 Kg to 50 Kg. The new facility also houses Azopharma’s new drug delivery company, ApiCross Drug Delivery Technologies which was launched at the 2007 AAPS Meeting & Exposition. According to Phil Meeks, CEO of Azopharma, “Our new facility allows us to expand our service offerings and take on larger scale projects to meet the needs of our pharmaceutical, biotechnology and medical device clients.” Specific Facility Highlights Include: Formulation Development Services Supporting Semi-Solids Liquids Solids Multi-Layer Tablets Lotions/Creams Gels Transdermal Patches Cytotoxic & Highly Potent Compound Development Services Facility/Equipment Advanced dust control system Analytical grade dry compressed air Full engineering staff including validation engineers, manufacturing engineers, manufacturing maintenance engineers and a validation specialist UPLC/MS-MS This new facility allows Azopharma to provide the full spectrum of development services required to be a leader in the industry. Mr. Meeks continued, “Azopharma Product Development Group is only one of a few organizations in the U.S. that are capable of developing a full spectrum of dosage forms from discovery through commercialization. By bringing together the best scientists in the field, state-of-the-art facilities and our focus on quality means that we can provide our partners a winning combination in total product development.”

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards